| 582751 |
11-keto Testosterone EIA Kit
|
|
- |
|
|
|
|
308.005167870802
|
11-keto-testosterone-eia-kit
|
11-keto Testosterone ELISA Kit; 11-KT EIA Kit
|
solid plates 11-kt hormones steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays |
308.005167870802
|
| 13571 |
13,14-dihydro-15-keto-tetranor Prostaglandin F1α
Exclusive
|
|
24379-94-0 |
≥98%
|
|
✓ |
2009-11-05
|
0.989823204420
|
13-14-dihydro-15-keto-tetranor-prostaglandin-f1
|
|
metabolites PGF1α PGF2α tetranors PGFM prostaglandins PGs urinary metabolites prostanoic acids C13 C-13 C14 C-14 C15 C-15 |
0.989823204420
|
| 10010064 |
15(S)-15-methyl Prostaglandin F2α ethyl amide
Exclusive
|
|
- |
≥95%
|
|
✓ |
2010-12-16
|
0.405745856353
|
15-s-15-methyl-prostaglandin-f2-ethyl-amide
|
15(S)-15-methyl PGF2α ethyl amide
|
uterus abortifacient labor prodrugs carboprosts methyl prostaglandins |
0.405745856353
|
| 10010063 |
15(S)-15-methyl Prostaglandin F2α isopropyl ester
Exclusive
|
|
157283-72-2 |
≥98%
|
|
✓ |
2010-12-16
|
0.540994475138
|
15-s-15-methyl-prostaglandin-f2-isopropyl-ester
|
15(S)-15-methyl PGF2α isopropyl ester
|
abortions uterus abortifacient labor prodrugs carboprosts prostaglandins PGs esters |
0.540994475138
|
| 10010103 |
16-phenoxy tetranor Prostaglandin F2α isopropyl ester
Exclusive
|
|
130209-78-8 |
>95%
|
|
✓ |
2011-01-26
|
3.954874155923
|
16-phenoxy-tetranor-prostaglandin-f2-isopropyl-ester
|
16-phenoxy tetranor PGF2α isopropyl ester
|
prostaglandins F2a F2alpha F2.alpha. F2-a F2-alpha F2-.alpha. F2α F2-α PGF2α FP receptors PGs analogs glaucoma luteolysis reproductive biology intraocular pressure IOP |
3.954874155923
|
| 10010562 |
16-phenoxy tetranor Prostaglandin F2α methyl amide
|
|
- |
≥98%
|
|
|
2011-01-24
|
0E-12
|
16-phenoxy-tetranor-prostaglandin-f2-methyl-amide
|
16-phenoxy tetranor PGF2α methyl amide
|
prostaglandins F2α PGF2α FP receptors analogs glaucoma luteolysis reproductive biology intraocular pressure IOP PGs |
0E-12
|
| 10010102 |
16-phenoxy tetranor Prostaglandin F2α methyl ester
Exclusive
|
|
51638-90-5 |
>98%
|
|
✓ |
2010-12-06
|
8.481005524861
|
16-phenoxy-tetranor-prostaglandin-f2-methyl-ester
|
16-phenoxy tetranor PGF2α
|
prostaglandins PGS PGF2α PGF2a PGF2.alpha. PGF2alpha FP receptors analogs glaucoma luteolysis reproductive biology intraocular pressures IOP |
8.481005524861
|
| 10010742 |
17-phenoxy trinor Prostaglandin F2α ethyl amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-11-29
|
14.922511300853
|
17-phenoxy-trinor-prostaglandin-f2-ethyl-amide
|
17-phenoxy trinor PGF2α ethyl amide
|
prostaglandins F2α PGF2α FP receptors smooth muscles contractions luteolysis IOP glaucoma PGs |
14.922511300853
|
| 13532 |
17-phenyl trinor Prostaglandin E2 ethyl amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-05-04
|
345.648555643251
|
17-phenyl-trinor-prostaglandin-e2-ethyl-amide
|
17-phenyl trinor PGE2 ethyl amide
|
17-phenyl trinor PGE2 agonists EP1 EP3 receptors EP4 smooth muscles contraction fertility prostaglandins PGs |
345.648555643251
|
| 9000686 |
17-phenyl trinor Prostaglandin F2α cyclohexyl amide
Exclusive
|
|
- |
≥95%
|
|
✓ |
2010-10-11
|
34.636896869244
|
17-phenyl-trinor-prostaglandin-f2-cyclohexyl-amide
|
Bimatoprost cyclohexyl amide
|
agonists FP receptors glaucoma intraocular pressure luteolysis parturition prostaglandins PGs |
34.636896869244
|
| 10010810 |
17-phenyl trinor Prostaglandin F2α cyclopropyl methyl amide
Exclusive
|
|
1138395-10-4 |
≥98%
|
|
✓ |
2011-01-25
|
17.882854511970
|
17-phenyl-trinor-prostaglandin-f2-cyclopropyl-methyl-amide
|
17-phenyl trinor PGF2α cyclopropyl methyl amide
|
prostaglandins F2α PGF2α FP receptors luteolysis analogs bimatoprosts glaucoma intraocular pressure IOP PGs |
17.882854511970
|
| 10010110 |
17-phenyl trinor Prostaglandin F2α methyl ester
Exclusive
|
|
38315-47-8 |
≥98%
|
|
✓ |
2011-01-19
|
17.882854511970
|
17-phenyl-trinor-prostaglandin-f2-methyl-ester
|
Bimatoprost methyl ester; 17-phenyl trinor PGF2α methyl ester
|
prostaglandins F2α PGF2α FP receptors luteolysis analogs latanoprosts glaucoma intraocular pressure IOP PGs bimatoprost |
17.882854511970
|
| 10010061 |
17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide
|
|
- |
>98%
|
|
|
2010-12-06
|
201.180505130228
|
17-trifluoromethylphenyl-trinor-prostaglandin-f2-ethyl-amide
|
17-trifluoromethylphenyl trinor PGF2α ethyl amide
|
trifluoro methyl phenyl trinor PGF2α amides prostaglandins PGs FP receotirs travoprost latanoprost glaucoma luteolysis reproductive bilogy |
201.180505130228
|
| 10010111 |
17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester
Exclusive
|
|
195503-20-9 |
≥98%
|
|
✓ |
2011-01-19
|
0.037127071823
|
17-trifluoromethylphenyl-trinor-prostaglandin-f2-methyl-ester
|
17-trifluoromethylphenyl trinor PGF2α methyl ester
|
prostaglandins F2α PGF2α FP receptors travoprosts latanoprosts glaucoma luteolysis reproductive biology PGs |
0.037127071823
|
| 10004970 |
(+)-5-trans Cloprostenol
|
|
57968-81-7 |
≥98%
|
|
|
2009-02-27
|
8.716620626151
|
-5-trans-cloprostenol
|
(+)-5-trans-16-m-chlorophenoxy tetranor PGF2α; (+)-5,6-trans Cloprostenol; D-Cloprostenol; (+)-5-trans-16-m-chlorophenoxy tetranor Prostaglandin F2α
|
PGF2.alpha. luteolysis isomer prostaglandins agonists FP receptors PGF2a |
8.716620626151
|
| 9000314 |
7(Z),11(Z)-Nonacosadiene
Exclusive
|
|
104410-91-5 |
≥98%
|
|
✓ |
2009-03-06
|
6.706104972376
|
7-z-11-z-nonacosadiene
|
|
pheromone drosophila d. melanogaster elongase |
6.706104972376
|
| 30001 |
cGMP Alprostadil
GMP API
|
|
745-65-3 |
|
|
|
|
0E-12
|
cgmp-alprostadil
|
Prostaglandin E1
|
|
0E-12
|
| 30024 |
cGMP Alprostadil-Alfadex
GMP API
|
|
93591-00-5 |
|
|
|
2009-06-26
|
0E-12
|
cgmp-alprostadil-alfadex
|
Prostaglandin E1 with α-cyclodextrin
|
|
0E-12
|
| 30004 |
cGMP (+)-Cloprostenol (sodium salt)
GMP API
|
|
62561-03-9 |
|
|
|
|
0E-12
|
cgmp-cloprostenol-sodium-salt
|
(+)-(16-m-chlorophenoxy)-17,18,19,20-tetranor-Prostaglandin F2α sodium salt
|
|
0E-12
|
| 30003 |
cGMP (±)-Cloprostenol (sodium salt)
GMP API
|
|
55028-72-3 |
|
|
|
|
0E-12
|
cgmp-cloprostenol-sodium-salt
|
(±)-(16-m-chlorophenoxy)-17,18,19,20-tetranor-PGF2α (sodium salt)
|
|
0E-12
|
| 30002 |
cGMP Dinoprostone
GMP API
|
|
363-24-6 |
|
|
|
|
0E-12
|
cgmp-dinoprostone
|
Prostaglandin E2
|
|
0E-12
|
| 30023 |
cGMP Oestrophan
GMP API
|
|
40665-92-7 |
|
|
|
|
0E-12
|
cgmp-oestrophan
|
10% ethanolic solution of (±)-Cloprostenol
|
|
0E-12
|
| 30025 |
cGMP Superphan
GMP API
|
|
54276-21-0 |
|
|
|
|
0E-12
|
cgmp-superphan
|
10% ethanolic solution of (+)-Cloprostenol
|
|
0E-12
|
| 10010016 |
(+)-Cloprostenol isopropyl ester
Exclusive
|
|
157283-66-4 |
≥98%
|
|
✓ |
2011-04-04
|
364.186636740332
|
-cloprostenol-isopropyl-ester
|
(+)-16-m-chlorophenoxy tetranor Prostaglandin F2α isopropyl ester
|
CAYMAXTM520 PGF2α luteolysis analogs prostaglandins agonists FP receptors enantiomers PGs optically active 15(R) 15R cyclopentenoic esters |
364.186636740332
|
| 10010495 |
(+)-Cloprostenol methyl amide
Exclusive
|
|
- |
≥98%
|
|
✓ |
2010-11-17
|
28.960880524861
|
-cloprostenol-methyl-amide
|
D-Cloprostenol methyl amide; (+)-16-m-Chlorophenoxy tetranor PGF2α methyl amide
|
analogs prosgaglandins PGs F2α PGF2α PGF2a PGF2alpha PGF2.alpha. F2a F2alpha F2.alpha. luteolytic luteolysis pregnancy abortion abortifacient estrus lipophilic synthetic FP agonist potent veterinary medicine vets agents treatments reporductiove disorders lipids free acids prodrugs pro-drugs pro drugs hydrolyzed tissues bioactive |
28.960880524861
|
| 10010115 |
(+)-Cloprostenol methyl ester
Exclusive
|
|
56687-85-5 |
≥98%
|
|
✓ |
2010-11-17
|
28.960880524861
|
-cloprostenol-methyl-ester
|
(+)-16-m-Chlorophenoxy tetranor PGF2α methyl ester; D-Cloprostenol methyl ester
|
analogs prosgaglandins PGs F2α PGF2α PGF2a PGF2alpha PGF2.alpha. F2a F2alpha F2.alpha. luteolytic luteolysis pregnancy abortion abortifacient estrus lipophilic synthetic FP agonist potent veterinary medicine vets agents treatments reporductiove disorders lipids |
28.960880524861
|
| 582251 |
Estradiol EIA Kit
|
|
- |
|
|
|
|
618.387053881354
|
estradiol-eia-kit
|
Estradiol ELISA Kit; β-Oestradiol EIA Kit; 17β-Estradiol EIA Kit; β-Estradiol EIA Kit
|
solid plates hormones E2 steroids measures kits eias enzyme immunoassays ELISAs endocrinology estrogen assays |
618.387053881354
|
| 582281 |
Estriol EIA Kit
|
|
- |
|
|
|
|
100.007527230379
|
estriol-eia-kit
|
Estriol ELISA Kit
|
solid plates hormones steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays 17b-estradiol 17beta-estradiol 17.beta.-estradiol 17β-estradiol estrogens estradiols pregnancy estriols fetal fetus dehydroepiandrosterone sulfates DHEAS adenal glands plasma blood urine saliva |
100.007527230379
|
| 500710 |
Follicle-Stimulating Hormone EIA Kit
|
|
- |
|
|
|
2011-09-30
|
182.968785546865
|
follicle-stimulating-hormone-eia-kit
|
FSH
|
kits assays EIAs ELISAs enzymes immunoassays measures measurements follicles FSH glycoproteins pituitary glands two subunits .alpha.-subunit alpha-subunit α-subunit .beta.-subunit beta-subunit β-subunit hormones luteinizing LH thyroid-stimulating TSH chorionic gonadotropin hCG gonadotropin-releasing GnRH Sertoli cells testis testes synthesis androgen-binding proteins spermatogenesis secretion inhibin negative feedback mechanisms granulosa ovary ovaries steroidogenesis ovulation immunometrics human serums |
182.968785546865
|
| 500720 |
Luteinizing Hormone EIA Kit
|
|
- |
|
|
|
2011-04-26
|
356.245666843387
|
luteinizing-hormone-eia-kit
|
LH EIA Kit
|
kits assays EIAs ELISAs enzymes immunoassays LH lutein hormones glycoproteins pituitary glands alpha-subunits .alpha.-subunits α-subunits beta-subunits .beta.-subunits β-subunits follicle stimulating FSH thyroid stimulating TSH chorionic gonadotropin hCG ovulation corpus luteum pregnancy testosterone testis biomarker homeostasis fertility regulation hypothalmic-pituitary-gonadal axis immunometric sandwich human serums |
356.245666843387
|
| 11106 |
Nifedipine
|
|
21829-25-4 |
≥98%
|
|
|
2011-11-22
|
0.798342541436
|
nifedipine
|
Nifediac™; BAY 1040; Procardia™; Adalat™; Nifedical™; Cordipin
|
dihydropyridine calcium channel blockers Ca2+ hypertension angina endothelia cardiology preterm labor Raynaud’s phenomenon pulmonary edema coronary vasodilator antioxidant gastric acids 11104-22-6 101539-70-2 101554-38-5 adalat nifediac cordipin procardia nifedical adalate adapine adapress alat alfadat alonix angipec anifed BAY-1040 BAY1040 BAY-a BAYa BAY-a 1040 bonacid calcigard calcibloc calciguard calcilat camont cardifen cardionorm chronadalate coral cordafen cordaflex cordilan corinfar corotrend corynphar depin dignokonstant dilafed dilcor duranifin ecodipin fedcor fenamon fedipin fenihidine glopir hadipine hexadilat introcar kordafen macorel megalat myogard nifedilat nifedirex nifelantern nifelat nifensar niphedipine nyefax orix oxcord pidilat procardia sepamit TN 873R TN-873R TN873R tensopin tibricol UV-ENP 349PINa vasdalat vasofed xinran zenusin |
0.798342541436
|
| 582601 |
Progesterone EIA Kit
|
|
- |
|
|
|
|
319.014420263994
|
progesterone-eia-kit
|
Progesterone ELISA Kit
|
solid plates hormones E2 steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays |
319.014420263994
|
| 500730 |
Prolactin (human) EIA Kit
New
|
|
- |
|
|
|
2012-02-28
|
187.650827951974
|
prolactin-human-eia-kit
|
|
kits assays EIAs ELISAs enzymes immunoassays measures measurements polypeptides hormones synthesized secreted anterior pituitary glands placentas decidua immune systems cells cellular T B NK body fluids plasmas amniotic milk mucosal secretions cerebrospinal CSF mammary lactation surfactants lungs pulmonary fetal fetus pregnancy tolerance immuno-regulatory reproduction reproductive functions breast cancers estrogens maturation ovulatory cycles ovulation inhibits inhibition inhibitors FSH follicle-stimulating GnRH Gonadotropin-releasing gonads gonadal hypogonadism erectile dysfunctions immunometrics sandwich humans serums |
187.650827951974
|
| 10384 |
Prostaglandin E2 isopropyl ester
Exclusive
|
|
71845-66-4 |
≥98%
|
|
✓ |
2010-06-07
|
344.740252565114
|
prostaglandin-e2-isopropyl-ester
|
|
PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic |
344.740252565114
|
| 11017 |
Retinoic Acid
|
|
302-79-4 |
≥98%
|
|
|
2011-10-25
|
17.543287906690
|
retinoic-acid
|
ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578
|
ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans |
17.543287906690
|
| 13258 |
Tamoxifen
|
|
10540-29-1 |
≥98%
|
|
|
2010-01-21
|
75.908419802325
|
tamoxifen
|
|
nuclear receptors 17β-estradiol estrogen ERα ERβ modulators antagonists breast cancers tumors agonists bones osteoporosis cardiovascular disease menopause women uterus uterine endometrial carcinomas Nolvadex Istubal Valodex Savient brand of Tamoxifen Citrate
Citrate Tamoxifen
Tamoxifen Citrate
Zitazonium Tomaxithen ICI-4 474 ICI 46 474Tamoxifen ICI-47699 ICI-46474 ICI46474ICI 47699 ICI 46474 Soltamox Novaldex Nolvadex ICI47699 ICI46474 |
75.908419802325
|
| 11629 |
Tamoxifen (citrate)
New
|
|
54965-24-1 |
≥98%
|
|
|
2012-04-04
|
71.420949142938
|
tamoxifen-citrate
|
ICI 46474; Nolvadex; Istubal; Noltam; Kessar; TMX; Valodex; Zemide
|
7244-97-5 I.C.I.46474 citrate tamofen tamoplex tamox-puren tomaxasta Z-tamoxifen citrate nourytam ICI-46474 ICI46474 estrogen receptors cancers breasts agonists antagonists cholesterol modulators ER adjuvants bones uterus tissues cytochromes P450 CYP450 endoxifen cells apotosis autophagy differentiation |
71.420949142938
|
| 582701 |
Testosterone EIA Kit
|
|
- |
|
|
|
|
578.455430106776
|
testosterone-eia-kit
|
Testosterone ELISA Kit
|
solid plates hormones E2 steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays |
578.455430106776
|
| 13632 |
Tiaprost
New
|
|
71116-82-0 |
≥95%
|
|
|
2012-01-27
|
7.284776703498
|
tiaprost
|
Iliren
|
prostaglandins PGs analogs PGF2α estrus endometritis parturition veterinary medicine luteolysis |
7.284776703498
|